Genelux Corporation (GNLX) Financials

GNLX Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 32.4 million 9.5 million
Dec. 31, 2025 19.0 million 7.5 million
Sept. 30, 2025 25.0 million 6.4 million
June 30, 2025 32.2 million 8.3 million

GNLX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -7.0 million 1.4 million
Dec. 31, 2025 -6.6 million 810000
Sept. 30, 2025 -7.1 million 2.3 million
June 30, 2025 -7.2 million 1.3 million

GNLX Net Income

No data available :(

GNLX Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 26.2 million 2.2 million -
Dec. 31, 2025 14.6 million 1.3 million 1.7 million
Sept. 30, 2025 20.9 million 1.3 million 1.6 million
June 30, 2025 28.0 million - 1.4 million

GNLX Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 32.5 million
Dec. 31, 2025 37.2 million
Sept. 30, 2025 37.9 million
June 30, 2025 37.9 million

GNLX Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 921000 5.2 million 3.1 million -
Dec. 31, 2025 436000 5.7 million 3.8 million -
Sept. 30, 2025 517000 4.7 million 3.5 million -
June 30, 2025 115000 4.8 million 3.0 million -

GNLX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - 1000
Dec. 31, 2025 8000 148000
Sept. 30, 2025 - -
June 30, 2025 - 143000

GNLX

Price: $2.96

52 week price:
2.29
8.54

Earnings Per Share: -0.85 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 110.2 million

Links: